CCL4 and Hepatic fibrosis: Despite the evidence on the role of miR-21 and fibrosis, a recent study found that antisense inhibition or genetic deletion of miR-21 does not alter HSC activation or liver fibrosis in CCL4 induced liver fibrosis mice models (29).